Pfizer gives cactus drug green light
Drugs giant Pfizer is to press ahead with the development of a plant-based appetite suppressant for the treatment of obesity after reaffirming its commitment to a licensing deal with botanical
Drugs giant Pfizer is to press ahead with the development of a plant-based appetite suppressant for the treatment of obesity after reaffirming its commitment to a licensing deal with botanical